# High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer

> **NCT00988130** · PHASE2 · UNKNOWN · sponsor: **University College London Hospitals** · enrollment: 26 (estimated)

## Conditions studied

- Prostate Cancer
- Sexual Dysfunction

## Interventions

- **OTHER:** laboratory biomarker analysis
- **OTHER:** questionnaire administration
- **PROCEDURE:** assessment of therapy complications
- **PROCEDURE:** high-intensity focused ultrasound ablation
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00988130
- **Lead sponsor:** University College London Hospitals
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00988130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00988130, "High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00988130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*